Clinical Trial Update: Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics) [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports the long-term clinical experience with Atacand (candesartan) in hypertensive children aged 1 to under 11 years, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-29